Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Lyophilised high-purity lab material for research use only
They contain the same active ingredient semaglutide, tirzepatide or orforglipron but add minor but clinically important modifications such as using a different salt form, adding different inactive ingredients and varying drug concentrations or dosages
These characteristics have made GLP-1 medicines a crucial part of managing type 2 diabetes, along with indications that some GLP-1 receptor agonists can enhance cardiovascular outcomes
It is marketed under the brand names Wegovy, approved for weight management, and Ozempic, approved for type 2 diabetes management
US$ 29.91
US$ 29.44
US$ 28.06
US$ 22.57
